3 July 2024

Clinical Obesity

Obesity: Moving forward

1 July 2024

Obesity Pharmaceuticals Research Sleep Sleep apnoea

Tirzepatide halves obstructive sleep apnoea severity

1 July 2024

Diabetes Obesity Political TGA

First generic GLP-1 RAs in the approval pipeline

27 June 2024

ADHD Obesity Pregnancy

Synthetic oxytocin doesn’t raise ADHD, ASD risk

24 June 2024

Obesity Political

Ozempic in Oz is cheap as chips (but rare as hen’s teeth)

6 June 2024

Diabetes Gastroenterology Obesity Pharmaceuticals Surgery

GLP-1 RAs bring surgical risks

5 June 2024

Clinical Diet Fertility Obesity

Major drivers of obesity, diabetes and coronary artery disease

5 June 2024

cardiovascular Diabetes Obesity

Semaglutide reduces CV events, with or without weight loss

28 May 2024

Clinical Obesity

Intragastric balloon-based program for weight loss

22 May 2024

Diabetes Obesity Pharmacy Political

Ozempic compounded in ‘disgusting’ conditions

22 May 2024

Diabetes Obesity Political TheHill

Butler slaps ban on compounded semaglutide and tirzepatide

20 May 2024

Clinical Obesity

BMI of 27 equals obesity in over-40s

13 May 2024

Iron deficiency Nutrition Obesity Paediatrics

Iron deficiency risk increases in overweight and obese children

10 May 2024

Obesity Political Telehealth

No doctor, no script, no worries: here’s your Ozempic

7 May 2024

Obesity Tax

A tiered sugary drinks tax can help fight obesity

18 April 2024

Obesity Pharmacy

‘Turbocharged’ $160bn market for obesity drugs by 2030